ArticleCell chemical biology2018

SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.

John M Hatcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.